NDC codes

415464 NDC codes with hospital pricing data in the network.

• NDC 21922-0029-04 — Mupirocin 2% topical creamAI (154 hospitals, 28,828–29,674 samples)
• NDC 16729-0171-01 — Amitriptyline 10 mg tabletAI (644 hospitals, 29,031–29,670 samples)
• NDC 61314-0227-15 — Timolol eye drops 0.5% (15 mL bottle)AI (245 hospitals, 28,842–29,670 samples)
• NDC 43598-0549-10 — Propofol intravenous emulsion, 1000 mg per 100 mLAI (348 hospitals, 27,270–29,664 samples)
• NDC 00264-7520-20 — Dextrose 10% intravenous solutionAI (343 hospitals, 28,475–29,645 samples)
• NDC 50742-0372-01 — Buprenorphine 5 mcg/hour weekly skin patchAI (127 hospitals, 28,827–29,628 samples)
• NDC 10702-0018-01 — oxyCODONE 5 mg tabletAI (440 hospitals, 28,815–29,625 samples)
• NDC 70860-0301-10 — Diltiazem injection, 5 mg per mLAI (258 hospitals, 29,079–29,619 samples)
• NDC 60687-0465-01 — SPIRONOLACTONE 25 MG TABLETAI (430 hospitals, 28,703–29,612 samples)
• NDC 00078-0729-10 — Betaxolol eye drops suspensionAI (333 hospitals, 28,794–29,604 samples)
• NDC 80830-1188-07 — Propofol injection 10 mg/mL, 20 mLAI (97 hospitals, 13,628–29,603 samples)
• NDC 68462-0130-01 — Zonisamide 100 mg capsulesAI (364 hospitals, 28,945–29,602 samples)
• NDC 75834-0158-01 — Verapamil 180 mg extended-release tabletAI (737 hospitals, 28,870–29,590 samples)
• NDC 51862-0454-01 — Clonidine 0.2 mg/24 hr weekly patchAI (206 hospitals, 28,815–29,589 samples)
• NDC 51862-0454-04 — Clonidine 0.2 mg/24-hour transdermal patchAI (266 hospitals, 28,815–29,589 samples)
• NDC 69374-0956-10 — Phenylephrine 80 mcg/mL IV syringeAI (51 hospitals, 28,828–29,584 samples)
• NDC 72266-0122-01 — Metoprolol tartrate 5 mg/5 mL IV solutionAI (145 hospitals, 28,891–29,566 samples)
• NDC 00143-9873-01 — Metoprolol tartrate 5 mg/5 mL IV solutionAI (149 hospitals, 28,836–29,565 samples)
• NDC 00019-1323-70 — Ioversol contrast dye for imaging, IV syringeAI (25 hospitals, 28,710–29,565 samples)
• NDC 00407-1413-69 — Iohexol 300 contrast solutionAI (62 hospitals, 28,710–29,565 samples)
• NDC 09991-2305-00 — Iohexol 350 contrast dye for intravenous useAI (24 hospitals, 28,710–29,565 samples)
• NDC 88888-0028-08 — Iohexol 300 contrast dye for intravenous useAI (24 hospitals, 28,710–29,565 samples)
• NDC 88888-0028-07 — Iopamidol 61% iodine contrast injectionAI (24 hospitals, 28,710–29,565 samples)
• NDC 00409-1582-19 — Bupivacaine 0.75% local anesthetic injectionAI (138 hospitals, 26,520–29,562 samples)
• NDC 00409-4888-20 — Sodium chloride 0.9% preservative-free injectionAI (417 hospitals, 28,248–29,562 samples)
• NDC 00378-3349-16 — Estradiol 0.025 mg/24 hr transdermal patchAI (154 hospitals, 28,812–29,559 samples)
• NDC 50268-0411-11 — Hydrocortisone rectal suppository 25 mgAI (136 hospitals, 28,812–29,559 samples)
• NDC 64980-0514-15 — Timolol eye drops 0.5% solutionAI (157 hospitals, 28,812–29,559 samples)
• NDC 16571-0676-16 — Hydrocortisone 25 mg rectal suppositoryAI (74 hospitals, 28,812–29,559 samples)
• NDC 00113-1720-11 — Mometasone nasal spray 50 mcgAI (25 hospitals, 28,812–29,559 samples)
• NDC 51079-0436-20 — Doxepin 10 mg capsulesAI (642 hospitals, 28,891–29,557 samples)
• NDC 76204-0100-30 — Ipratropium bromide 0.02% inhalation solutionAI (423 hospitals, 28,629–29,556 samples)
• NDC 62559-0511-01 — indapamide 2.5 mg tabletAI (474 hospitals, 28,941–29,553 samples)
• NDC 60687-0598-01 — Propranolol 20 mg tabletsAI (415 hospitals, 28,815–29,544 samples)
• NDC 51079-0103-20 — Spironolactone 25 mg tabletsAI (602 hospitals, 28,889–29,537 samples)
• NDC 62584-0265-01 — Metoprolol tartrate 25 mg tabletsAI (563 hospitals, 27,077–29,534 samples)
• NDC 33342-0333-80 — TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL OINTMENTAI (161 hospitals, 28,514–29,531 samples)
• NDC 00093-3657-21 — Buprenorphine weekly transdermal patch, 10 mcg per hourAI (179 hospitals, 28,683–29,529 samples)
• NDC 70004-0604-09 — Ephedrine injection in a prefilled syringeAI (62 hospitals, 28,817–29,528 samples)
• NDC 00121-0595-30 — Sodium citrate and citric acid oral solutionAI (167 hospitals, 28,942–29,527 samples)
• NDC 65862-0192-01 — Fluoxetine 10 mg capsulesAI (521 hospitals, 28,868–29,525 samples)
• NDC 00093-1061-01 — sotalol 80 mg tabletAI (465 hospitals, 28,773–29,520 samples)
• NDC 71266-5103-01 — Oxytocin in sodium chloride IV solutionAI (340 hospitals, 29,112–29,517 samples)
• NDC 00143-9587-25 — Glycopyrrolate 0.2 mg/mL injectionAI (97 hospitals, 29,453–29,489 samples)
• NDC 24208-0735-06 — Cyclopentolate 1% eye dropsAI (382 hospitals, 28,439–29,483 samples)
• NDC 51991-0838-01 — Cyproheptadine 4 mg tabletsAI (277 hospitals, 28,883–29,477 samples)
• NDC 50111-0648-01 — FLUoxetine 20 mg capsuleAI (475 hospitals, 28,843–29,464 samples)
• NDC 68084-0895-09 — Hydrocodone-acetaminophen 5/325 mg tabletsAI (244 hospitals, 28,701–29,457 samples)
• NDC 00409-4887-50 — Sterile water for injectionAI (505 hospitals, 28,664–29,456 samples)
• NDC 47781-0587-20 — Metoprolol tartrate 5 mg/5 mL IV solutionAI (114 hospitals, 28,818–29,448 samples)